Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christoph Wanner

Showing results (151-160 of 785) with videos related to

Pageof 79
Sort By:
European Journal of Clinical Investigation|November 5, 2011
Interdisciplinary approach towards female patients with Fabry diseaseFrank Weidemann, Markus Niemann, Claudia Sommer, et al.
Journal of the American Society of Nephrology : JASN|February 22, 2001
Oxidized LDL suppresses NF-kappaB and overcomes protection from apoptosis in activated endothelial cellsKathrin Heermeier, Wolfgang Leicht, Alois Palmetshofer, et al.
Deutsche Medizinische Wochenschrift (1946)|March 23, 2017
[The Fabry's Disease Cardiomyopathy as Differential Diagnosis of Acute Coronary Syndrome]Daniel Oder, Stefan Störk, Christoph Wanner, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 11, 2003
Tubular staining of modified C-reactive protein in diabetic chronic kidney diseaseSusanne B Schwedler, Frank Guderian, Jobst Dämmrich, et al.
BMC Nephrology|January 8, 2025
Risk prediction modeling for cardiorenal clinical outcomes in patients with non-diabetic CKD using US nationwide real-world dataChristoph Wanner, Johannes Schuchhardt, Chris Bauer, et al.
BMC Nephrology|April 9, 2025
Associations between intercurrent events and cardiorenal clinical outcomes in non-diabetic chronic kidney disease: a real-world retrospective cohort study in the United StatesChristoph Wanner, Johannes Schuchhardt, Chris Bauer, et al.
Innere Medizin (Heidelberg, Germany)|February 11, 2025
[Ways to improve vaccination rates : Indication vaccinations for adults]Jürgen Floege, Toralf Schwarz, Christoph Wanner, et al.
Kidney International|February 22, 2025
The prevention and management of chronic kidney disease among patients with metabolic syndromeDoreen Zhu, Parminder K Judge, Christoph Wanner, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|December 5, 2013
The effects of colestilan versus placebo and sevelamer in patients with CKD 5D and hyperphosphataemia: a 1-year prospective randomized studyFrancesco Locatelli, Goce Spasovski, Nada Dimkovic, et al.
Plos One|December 17, 2020
Survey about do-it-yourself closed loop systems in the treatment of diabetes in GermanyAnna Laura Herzog, Jonas Busch, Christoph Wanner, et al.
Pageof 79

Showing results (151-160 of 785) with videos related to

Sort By:
Pageof 79
European Journal of Clinical Investigation|November 5, 2011
Interdisciplinary approach towards female patients with Fabry diseaseFrank Weidemann, Markus Niemann, Claudia Sommer, et al.
Journal of the American Society of Nephrology : JASN|February 22, 2001
Oxidized LDL suppresses NF-kappaB and overcomes protection from apoptosis in activated endothelial cellsKathrin Heermeier, Wolfgang Leicht, Alois Palmetshofer, et al.
Deutsche Medizinische Wochenschrift (1946)|March 23, 2017
[The Fabry's Disease Cardiomyopathy as Differential Diagnosis of Acute Coronary Syndrome]Daniel Oder, Stefan Störk, Christoph Wanner, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 11, 2003
Tubular staining of modified C-reactive protein in diabetic chronic kidney diseaseSusanne B Schwedler, Frank Guderian, Jobst Dämmrich, et al.
BMC Nephrology|January 8, 2025
Risk prediction modeling for cardiorenal clinical outcomes in patients with non-diabetic CKD using US nationwide real-world dataChristoph Wanner, Johannes Schuchhardt, Chris Bauer, et al.
BMC Nephrology|April 9, 2025
Associations between intercurrent events and cardiorenal clinical outcomes in non-diabetic chronic kidney disease: a real-world retrospective cohort study in the United StatesChristoph Wanner, Johannes Schuchhardt, Chris Bauer, et al.
Innere Medizin (Heidelberg, Germany)|February 11, 2025
[Ways to improve vaccination rates : Indication vaccinations for adults]Jürgen Floege, Toralf Schwarz, Christoph Wanner, et al.
Kidney International|February 22, 2025
The prevention and management of chronic kidney disease among patients with metabolic syndromeDoreen Zhu, Parminder K Judge, Christoph Wanner, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|December 5, 2013
The effects of colestilan versus placebo and sevelamer in patients with CKD 5D and hyperphosphataemia: a 1-year prospective randomized studyFrancesco Locatelli, Goce Spasovski, Nada Dimkovic, et al.
Plos One|December 17, 2020
Survey about do-it-yourself closed loop systems in the treatment of diabetes in GermanyAnna Laura Herzog, Jonas Busch, Christoph Wanner, et al.
Pageof 79